title: Cyclodextrins inhibit replication of scrapie prion protein in cell culture.
abstract: Prion diseases are fatal neurodegenerative disorders that are caused by the conversion of a normal host-encoded protein, PrP(C), to an abnormal, disease-causing form, PrP(Sc). This paper reports that cyclodextrins have the ability to reduce the pathogenic isoform of the prion protein PrP(Sc) to undetectable levels in scrapie-infected neuroblastoma cells. Beta-cyclodextrin removed PrP(Sc) from the cells at a concentration of 500 microM following 2 weeks of treatment. Structure activity studies revealed that antiprion activity was dependent on the size of the cyclodextrin. The half-maximal inhibitory concentration (IC(50)) for beta-cyclodextrin was 75 microM, whereas alpha-cyclodextrin, which possessed less antiprion activity, had an IC(50) of 750 microM. This report presents cyclodextrins as a new class of antiprion compound. For decades, the pharmaceutical industry has successfully used cyclodextrins for their complex-forming ability; this ability is due to the structural orientation of the glucopyranose units, which generate a hydrophobic cavity that can facilitate the encapsulation of hydrophobic moieties. Consequently, cyclodextrins could be ideal candidates for the treatment of prion diseases.
authors: School of Biomolecular and Biomedical Science, University College Dublin, Belfield Campus, Dublin 4, Ireland.
authors: Marguerite
authors: M
authors: Prior
authors: Sylvain
authors: S
authors: Lehmann
authors: Man-Sun
authors: MS
authors: Sy
authors: Brendan
authors: B
authors: Molloy
authors: Hilary E M
authors: HE
authors: McMahon
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D003505:Cyclodextrins / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D020128:Inhibitory Concentration 50; D051379:Mice; D009447:Neuroblastoma; D018620:PrPSc Proteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000472:pathogenicity; D017096:Prion Diseases / Q000188:drug therapy; D013329:Structure-Activity Relationship; D014162:Transfection; D047391:alpha-Cyclodextrins / Q000494:pharmacology; D047392:beta-Cyclodextrins / Q000494:pharmacology
chemical_list: D003505:Cyclodextrins; D018620:PrPSc Proteins; D047391:alpha-Cyclodextrins; D047392:beta-Cyclodextrins; C031215:betadex; C032613:alpha-cyclodextrin
references: J Biol Chem. 1997 Mar 7;272(10):6324-31
references: 9045652
references: J Chromatogr A. 1997 May 9;769(2):209-14
references: 9188180
references: J Biol Chem. 1999 Jul 23;274(30):20763-71
references: 10409615
references: J Cell Biol. 2000 Mar 6;148(5):997-1008
references: 10704449
references: J Virol. 2000 Jan;74(1):320-5
references: 10590120
references: J Lipid Res. 1997 Nov;38(11):2264-72
references: 9392424
references: Mol Biol Cell. 1992 Aug;3(8):851-63
references: 1356522
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2333-8
references: 9122195
references: Mol Membr Biol. 2006 Jan-Feb;23(1):89-99
references: 16611584
references: J Neurochem. 2005 Mar;92(6):1477-86
references: 15748165
references: Science. 2000 Feb 25;287(5457):1503-6
references: 10688802
references: J Biol Chem. 1993 Feb 15;268(5):3150-5
references: 8428991
references: Annu Rev Biochem. 1998;67:793-819
references: 9759504
references: Proc Natl Acad Sci U S A. 1986 Apr;83(8):2310-4
references: 3085093
references: J Neurochem. 1992 Aug;59(2):768-71
references: 1352803
references: J Biol Chem. 2002 Mar 29;277(13):11292-6
references: 11792705
references: J Virol. 2000 Apr;74(7):3135-40
references: 10708429
references: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3416-21
references: 12626750
references: J Biol Chem. 2004 Mar 19;279(12):11170-8
references: 14711812
references: FASEB J. 2002 Oct;16(12):1526-36
references: 12374775
references: J Gen Virol. 1992 Mar;73 ( Pt 3):661-5
references: 1372039
references: J Biol Chem. 1991 Sep 25;266(27):18217-23
references: 1680859
references: J Cell Biol. 1990 Dec;111(6 Pt 2):2931-8
references: 2148564
references: Chem Pharm Bull (Tokyo). 2004 Aug;52(8):900-15
references: 15304981
references: EMBO J. 1997 Sep 15;16(18):5501-8
references: 9312009
references: Ann N Y Acad Sci. 2000;924:62-7
references: 11193803
references: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3966-71
references: 9520476
references: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
references: 9811807
references: Cell. 1992 Feb 7;68(3):533-44
references: 1531449
references: Chem Rev. 1998 Jul 30;98(5):1743-1754
references: 11848947
references: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14945-9
references: 8962161
references: J Gen Virol. 1999 Apr;80 ( Pt 4):1079-85
references: 10211979
references: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962-6
references: 7902575
references: Neurology. 1992 Jan;42(1):149-56
references: 1346470
references: FEBS Lett. 1994 Mar 21;341(2-3):256-8
references: 7907994
references: J Biol Chem. 2004 Apr 9;279(15):14983-90
references: 14754889
references: Biophys J. 2001 Oct;81(4):2257-67
references: 11566796
references: Subcell Biochem. 2004;37:167-215
references: 15376621
references: J Clin Invest. 2002 Sep;110(5):597-603
references: 12208858
references: J Clin Invest. 2002 Jul;110(1):3-8
references: 12093880
references: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13079-84
references: 12271119
references: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12117-22
references: 9770449
references: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references: 7638184
references: J Mol Biol. 2000 Aug 18;301(3):567-73
references: 10966770
references: Nature. 2001 Aug 16;412(6848):739-43
references: 11507642
references: Proc Natl Acad Sci U S A. 1998 May 26;95(11):6460-4
references: 9600988
references: Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9
references: 11413487
references: J Biol Chem. 1993 Sep 25;268(27):20276-84
references: 8104185
references: J Lipid Res. 2004 Feb;45(2):396-401
references: 14563821
references: Arch Gerontol Geriatr. 1997 Jul-Aug;25(1):41-58
references: 15374100
references: J Pharmacol Exp Ther. 2004 Aug;310(2):745-51
references: 15082751
references: J Cell Biol. 1995 Apr;129(1):121-32
references: 7698979
references: Nat Rev Drug Discov. 2004 Dec;3(12):1023-35
references: 15573101
references: Bioconjug Chem. 1993 Sep-Oct;4(5):372-9
references: 8274523
references: Chem Rev. 1998 Jul 30;98(5):2045-2076
references: 11848959
references: Science. 1991 Jun 14;252(5012):1515-22
references: 1675487
references: Biotechnol Adv. 2002 Dec;20(5-6):341-59
references: 14550020
references: Biochem Biophys Res Commun. 2002 Oct 4;297(4):1011-15
references: 12359256
references: Mech Ageing Dev. 2000 Jul 31;116(2-3):193-218
references: 10996019
references: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14529-34
references: 10588739
references: Science. 2000 Sep 15;289(5486):1925-8
references: 10988071
references: J Virol. 1993 Oct;67(10):6270-2
references: 8103804
references: Cell. 1987 Oct 23;51(2):229-40
references: 2444340
references: EMBO J. 2001 Aug 1;20(15):3957-66
references: 11483499
references: Proc Natl Acad Sci U S A. 2000 May 23;97(11):6073-8
references: 10823951
references: Biochem Biophys Res Commun. 1997 Nov 7;240(1):1-7
references: 9367871
references: Eur J Biochem. 1989 Dec 8;186(1-2):17-22
references: 2598927
references: Drugs Today (Barc). 2002 Jan;38(1):49-58
references: 12532184